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Summary
During development, wound repair and disease-related pro-
cesses, such as cancer, normal, or neoplastic cell types traffic
through the extracellularmatrix (ECM), the complex compos-
ite of collagens, elastin, glycoproteins, proteoglycans, and gly-
cosaminoglycans that dictate tissue architecture. Current ev-
idence suggests that tissue-invasive processes may proceed by
protease-dependent or protease-independent strategieswhose
selection is not only governed by the characteristics of the
motile cell population, but also by the structural properties of
the intervening ECM. Herein, we review the mechanisms by
which ECM dimensionality, elasticity, crosslinking, and pore
size impact patterns of cell invasion. This summary should
prove useful when designing new experimental approaches
for interrogating invasion programs as well as identifying po-
tential cellular targets for next-generation therapeutics.
Introduction
In cancer, neoplastic cells inappropriately co-opt normal
cell function and escape from their primary locale by en-
gaging invasive machinery that had been ostensibly engi-
neered to control the regulated motility programs opera-
tive during growth and development (Rowe & Weiss, 2009;
Kessenbrock et al., 2010; Wolf & Friedl, 2011). Tumour pro-
gression and invasion are often linked to the up-regulated
expression of proteolytic enzymes—generated by both cancer
cells and the surrounding tumour microenvironment—that
are capable of degrading themajor extracellularmatrix (ECM)
macromolecules that comprise all connective tissues (Rowe &
Weiss, 2009; Kessenbrock et al., 2010; Wolf & Friedl, 2011;
Lu et al., 2012). To date, multiple proteases have been im-
plicated in the ECM remodelling events associated with can-
cer, but conflicting results have been reported which question
the issue of whether proteolysis is an obligate step in tissue-
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invasive processes (Rowe & Weiss, 2009; Sabeh et al., 2009;
Sabeh et al., 2009b; Kessenbrock et al., 2010; Wolf & Friedl,
2011).Whereas many groups have reported that cancer cells
can only traverse the ECMvia the proteolytic dissolution of in-
tervening structural barriers, others have proposed that neo-
plastic cells can push or squeeze their way through matrix
barrierswithoutmobilizingproteases (Wolf et al., 2003,2007;
Sabeh et al., 2004; Sabeh et al., 2009; Madsen & Sahai, 2010;
Wolf & Friedl, 2011; Friedl et al., 2012). As such, emerging
models of invasion will be reviewed in an effort to help re-
solve apparent inconsistencies in the field and to outline new
experimental approaches that may be applied to outstanding
questions.
ECM-based models for proteolytic and nonproteolytic cell invasion
and migration
To define the mechanisms that allow cancer cells to infiltrate
ECM barriers by protease-dependent or protease-independent
processes, a number of in vitro, ex vivo, and in vivo models
have been developed (Rowe & Weiss, 2008, 2009; Ehrbar
et al., 2011; Wolf & Friedl, 2011; Friedl et al., 2012; Petrie
et al., 2012). In overview, these models have been developed
to analyze the mechanisms by which neoplastic cells invade
the twomajor ECM subtypes, that is the basement membrane
(BM) and the interstitium (Rowe&Weiss, 2008, 2009; Ehrbar
et al., 2011;Wolf & Friedl, 2011; Friedl et al. 2012; Petrie et al.,
2012). As each construct displays its own unique mix of ex-
perimental strengths and weaknesses, insights may only be
gleaned from such studies with an appreciation of the limita-
tions inherent in these systems.
Basement membrane
All epithelial layers are subtended by a several hundred
nanometer-thick, sheet-like BM, largely comprised of two
interlocking networks of heterotrimeric type IV collagen and
laminin isoforms which are further interwoven with 25
or more distinct glycoproteins and proteoglycans (Candiello
et al., 2007; Rowe & Weiss, 2008; Balasubramani et al.,
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2010; Yurchenco, 2011). BM constituents are distributed in
a tissue-specific fashion that varies with developmental stage
(Kabosova et al., 2007; Bai et al., 2009; Candiello et al., 2010).
Despite their heterogeneity, the structural andmechanical in-
tegrityofBMsisdeterminedprimarilybytypeIVcollagenintra-
and inter-molecular covalent crosslinks that include disulfide,
aldimine and newly characterized, peroxidasin-catalyzed sul-
filimine bonds (Rowe & Weiss, 2008; Vanacore et al., 2009;
Bhave et al., 2012; Weiss, 2012). Given an effective BM pore
diameter ranging from10 to90nm (as assessed by a battery of
electronandatomic forcemicroscopic techniques) (Yurchenco
& Ruben, 1987; Yurchenco et al., 1992; Abrams et al., 2000)
whose size is considerably smaller than the 1–2 µm pores
that migrating cells can negotiate, it is difficult to envision
a molecular mechanism that enables protease-independent
cancer cell invasion across native BMs (Rowe &Weiss, 2008;
Wolf et al., 2013). Moreover, cell trafficking through the BM
during growth and development—in animal systems rang-
ing from primitive model organisms to higher vertebrates—is
tightly associated with proteolytic remodelling (Hotary et al.,
2006; Srivastava et al., 2007; Page-McCaw, 2008; Ota et al.,
2009; Rebustini et al., 2009; Matus et al., 2010; Yasunaga
et al., 2010). From where then has the proposition emerged
that proteases need not play a required role in allowing nor-
mal or neoplastic cells (of either epithelial or mesenchymal
origin) to traverse intact BMs? In large part, the conclusion
that cancer cells adopt a protease-independent, amoeboid-like
phenotype during BM invasion can be linked to the use of in
vitro constructs designed to recapitulate native BM structure
(Rowe & Weiss, 2008). Despite the fact that surface nanoto-
pography, rigidity, and BM macromolecular composition all
impact cell function, BM ‘mimics’ have, until recently, been
limited to the use of Matrigel, a self-assembling hydrogel de-
rived from tumour cell extracts (Gadea et al., 2007; Sahai
et al., 2007; Fackler & Grosse, 2008; Poincloux et al., 2011;
Rao et al., 2012; Tilghman et al., 2012). Matrigel, like native
BMs, contains type IV collagen and laminin, but the polymeric
complex is dominated by laminin (rather than type IV colla-
gen) and is largely devoid of the type IV collagen crosslinks
that define the structural properties of native BMs (Rowe &
Weiss, 2008). Indeed, unlike native BMs that remain insolu-
ble under harsh extraction conditions, Matrigel hydrogels are
readily solubilized by mild chaotropes (Rowe &Weiss, 2008).
Furthermore, recent studies demonstrate that the elasticmod-
ulus (i.e. rigidity) of Matrigel hydrogels is orders of magnitude
less than that of BMs assembled in vivo (Candiello et al., 2007;
Soofi et al., 2009). Difficulties in interpreting Matrigel-centric
experimental designs—at least with regard to invasion—are
further compounded by the frequent decision to embed tu-
mour cells within thick, 3-D hydrogels (Gadea et al., 2007;
Sahai et al., 2007; Poincloux et al., 2011). Whereas well ap-
preciated that cell behaviour is affected in distinct fashions
when cultured under 2-D versus 3-D conditions (Hotary et al.,
2003;Yamada&Cukierman,2007;Grinnell&Petroll, 2010),
normal epithelial cells as well as their transformed counter-
parts only interface a planar, 100–400 nm-thick BM layer in
the in vivo setting (Candiello et al., 2007; Rowe&Weiss, 2008;
Balasubramani et al., 2010). As such, the (patho)physiologic
relevance of monitoring cell invasion through a highly elastic
hydrogel definedby lowconcentrationsofnoncrosslinked type
IV collagen remains questionable (Rowe &Weiss, 2008).
To circumvent the limitations associated with BM mimet-
ics, recent studies have begun analyzing the invasion sys-
tems mobilized by normal or neoplastic cells as they trans-
migrate native BMs either under in vitro or in vivo conditions
(Hotary et al., 2006; Srivastava et al., 2007; Page-McCaw,
2008; Rowe & Weiss, 2008; Ota et al., 2009; Rebustini et al.,
2009; Rottiers et al., 2009; Matus et al., 2010; Schoumacher
et al., 2010; Yasunaga et al., 2010; Hagedorn & Sherwood,
2011). Remarkably, model organisms as well as mammalian
cells appear to share complementary BM invasion programs
that couple transmigrationwithECMproteolysis (Hotary et al.,
2006; Srivastava et al., 2007; Page-McCaw, 2008; Rowe &
Weiss, 2008; Ota et al., 2009; Rebustini et al., 2009; Rottiers
et al., 2009; Matus et al., 2010; Schoumacher et al., 2010;
Yasunaga et al., 2010; Hagedorn & Sherwood, 2011; Stevens
& Page-McCaw, 2012). In many of these systems, experimen-
tal results highlight key roles for membrane-tethered metal-
loenzymes belonging to the matrix metalloproteinase (MMP)
family, that is the so-called the membrane-type MMPs (MT-
MMPs) (Hotary et al., 2006; Srivastava et al., 2007; Page-
McCaw, 2008; Rowe & Weiss, 2008; Ota et al., 2009; Re-
bustini et al., 2009; Yasunaga et al., 2010). As this proteinase
classhas been the subject of recent reviews (Barbolina&Stack,
2008; Poincloux et al., 2009; Rowe &Weiss, 2009; Strongin,
2010), our discussion of these enzymes will be confined to a
short summary of their pertinent features. In mammals, six
MT-MMPs have been characterized. At least three of the MT-
MMPs (i.e. MT1-MMP,MT2-MMP andMT3-MMP) are able to
confer recipient cellswith the ability to proteolytically remodel
nativeBMstructures and trigger transmigration (Hotary et al.,
2006; Ota et al., 2009; Rebustini et al., 2009; Riggins et al.,
2010). Like all proteolytic enzymes, the MT-MMPs are syn-
thesized as proenzymes, and undergo intercellular activation
when their propeptide domains are proteolytically removed
during their transit through the trans-Golgi network to the
cell surface (Barbolina & Stack, 2008; Poincloux et al., 2009;
Rowe & Weiss, 2009; Golubkov et al., 2011). In most cases,
MT-MMPsappear to be directed to invadopodia-like structures
which allow cells to ‘focus’ their degradative potential to dis-
crete, subjacent zones that support ECM tunnelling programs
while maintaining the structural integrity of the surround-
ing matrix so as to support propulsive movement (Hotary
et al., 2006; Ota et al., 2009; Poincloux et al., 2009; Wang &
McNiven, 2012; Yu et al., 2012).Whereas recent studies have
emphasized the role of the 20-amino acid long MT1-MMP cy-
tosolic tail in regulating proteolytic and invasive activity (Wu
et al., 2005; Wang & McNiven, 2012; Yu et al., 2012), native
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BMbarriers can be transmigrated—in vitro aswell as in vivo—
in the absence of this domain (Hotary et al., 2006; Ota et al.,
2009). Importantly, MT-MMPs trigger BM remodelling and
transmigration programs that function independently of the
larger family of secreted MMPs, including the often-cited type
IV collagenases, MMP-2 and MMP-9, whose BM-degrading
activities remain unproven to date (Rowe &Weiss, 2008).
As Matrigel hydrogels do not recapitulate the structure of
native BMs, how is it that many reports have documented the
ability of inhibitors directed against secreted or membrane-
tetheredMMPs to block cell invasion through these constructs
[e.g., (Ueda et al., 2003;Zaman et al., 2006;Rizki et al., 2008)]?
Importantly, evenMMPs devoid of BM-degrading activity can
indirectly influence invasion programs by (i) processing ECM-
tethered growth factors to active intermediates, (ii) hydrolyz-
ing membrane-anchored ligands, (iii) activating/inactivating
secreted chemokines, or (iv) triggering motility independently
of proteolytic activity (Barbolina & Stack, 2008; Kessenbrock
et al., 2010; Strongin, 2010; Dufour et al., 2011; auf dem
Keller et al., 2013). In this regard, it should be stressed that
neither secreted MMPs nor members of any other protease
class have been shown to confer expressing cells with the
ability to traverse intact BMs (Hotary et al., 2006; Ota et al.,
2009).Consistentwithanaccessory, rather thanrequired role
for MMPs in Matrigel invasion, several groups have indepen-
dently confirmed the ability of multiple cell types to infiltrate
these hydrogels in the presence of MMP inhibitors (Even-Ram
& Yamada, 2005; Hotary et al., 2006; Rowe & Weiss, 2008;
Sodek et al., 2008; Poincloux et al., 2011). As the pore sizes
of these hydrogels are estimated to fall within the range of 1–
2 µm in diameter (assessed by quick-freeze transmission elec-
tron microscopy), MMP-independent invasion mechanisms
are most consistent with a model wherein the noncrosslinked
components of Matrigel can be mechanically displaced by the
migrating cancer cells (Poincloux et al., 2011).
Interstitium
The ECM of connective tissues is dominated by the intersti-
tial collagens (most commonly, type I collagen) that serve
as the single-most abundant extracellular proteins found in
mammals (Rowe & Weiss, 2009; Grinnell & Petroll, 2010).
Coincident with their secretion from fibroblasts, the colla-
gen propeptide domains are proteolytically removed, and a
complex auto-polymerization process is initiated (Kadler et al.,
2008). Upon lysyl oxidase-mediated crosslinking within the
N- and C-terminal nonhelical ends of the secreted and pro-
cessed collagen molecules (i.e. the telopeptide domains), the
fibrils mature into amechanically reinforced network of fibres
and fibre bundles (Eyre et al., 1984; Christiansen et al., 2000).
Given the tremendous tissue-to-tissue heterogeneity in inter-
stitial collagen content and crosslink structure (Eyre et al.,
1984; Christiansen et al., 2000; Kadler et al., 2008;Wolf et al.,
2009), trafficking cancer cells—as well as recruited stromal
cells—would be expected to encounter structurally distinct
barriers.
In considering the stratagems that might be deployed at
cell-ECM interfaces, a consensus of opinion is building to sup-
port a two-body model of invasion. In this model, the size and
elasticity of the infiltrating cell’s most mechanically rigid sub-
cellular compartment, that is thenucleus, dictates themanner
in which cells negotiate the fibrillar network of the interstitial
matrix (Nakayama et al., 2005;Wolf et al., 2007; Beadle et al.,
2008; Fisher et al., 2009; Friedl et al., 2011; Khatau et al.,
2012). If the dimensions of a rigid matrix pore are too small
to accommodate the nuclear dimensions of the trafficking cell,
the barrier will prove impassable unless the matrix is prote-
olytically remodelled. On the other hand, if the pore size of the
matrix is larger than the cell’s nuclear dimensions, a physical
barrier to cell traffic no longer exists, and invasion proceeds
independently of protease-dependent remodelling (Wolf et al.,
2013). A more complex invasion scheme is envisioned under
those circumstanceswhere the pore size is too small to support
passive cell movement, but the barrier might yet be negoti-
ated by either (i) ECM-degrading proteases (i.e. akin to cutting
through the bars of a ‘cage’), (ii) actomyosin motors and cell
adhesion molecules working in concert to mechanically dis-
tort the surrounding matrix—in this case, ‘bending’ the cage
bars (Friedrichs et al., 2007) or (iii) intracellular contractile
machinery that alters nuclear dimensions, thus permitting in-
vasion to proceed by cell ‘squeezing’ throughanondeformable
matrix cage (Nakayama et al., 2005; Beadle et al., 2008; Friedl
et al., 2011; Balzer et al., 2012; Khatau et al., 2012).Whereas
portions of these schemes remain somewhat conjectural in
nature, recent evidence culled from in vitro and in vivo systems
lends support to these models.
Protease-dependent migration in vitro: covalently crosslinked
collagen hydrogels
In vitro studies of cell behaviour in 3-D models of the in-
terstitial matrix have long relied on the use of acid ex-
tracts of rat tail tendons – both because of their ability to
yield relatively pure solutions of type I collagen as well as
the ability to recover full-length type I collagen molecules
with intact telopeptide domains (Sabeh et al., 2009). Us-
ing these extracts, collagen fibrillogenesis is initiated by ma-
nipulating pH, ionic strength and temperature (Raub et al.,
2007, 2008). Under standard conditions (i.e. pH ∼7.4, iso-
osmotic buffers and 37◦C), 2–4 mg/mL solutions of rat tail
tendon collagen yield an aldimine-crosslinked network of
fibrils with an effective pore diameter in the range of 1–
3 µm (Raub et al., 2007, 2008; Mickel et al., 2008). Us-
ing these matrices, a number of groups have consistently
reported that cancer cells—as well as normal endothelial,
fibroblast, bone marrow stromal/stem cells and smooth mus-
cle cells—display tissue-invasive behaviour that is solely
dependent on the mobilization of collagenolytic MMPs
C© 2013 The Authors
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(primarilyMT1-MMPorMT2-MMP,andperhaps,MT3-MMP)
(Sabehetal.,2004;Sodeketal.,2007,2008;Fisheretal.,2009;
Rowe &Weiss, 2009; Sabeh et al., 2009; Sabeh et al., 2009b;
Stratman et al., 2009; Lu et al., 2010; Sabeh et al., 2010;
Rowe et al., 2011). Given our previously described rules of
invasion, one presumes that the pores generated in these col-
lagen matrices are sufficiently small and rigid to preclude a
protease-independent motile response – a recently confirmed
prediction (Wolf et al., 2013). Two exceptions exist, however,
to the ‘protease required’ rule. First, after tissue-invasive cells
have ‘tunnelled’ through the collagenmatrix, patent passage-
ways can be created that allow trailing cells to follow the
proteolytic leader by distinct, protease-independent schemes
(though some reports have used type I collagen-Matrigel mix-
tures that may distort the fibrous structure of the network)
(Gaggioli et al., 2007; Dewitt et al., 2009; Fisher et al., 2009;
Carey et al., 2013). Hence, normal or neoplastic cells can tra-
verse crosslinked collagen matrices without mobilizing pro-
teases, but only if a passageway has already been cleared.
Second, unlike all other cancer cell types, myeloid cells (i.e.
leukocytes) freely traverse crosslinked hydrogels without pro-
teolyzing the collagen network (Lammermann et al., 2008;
Sabeh et al., 2009). Apparently, leukocytes negotiate collage-
nous barriers by applying two principles unavailable to other
cell types; (i) they do not rely heavily on integrins to estab-
lish cell-matrix adhesive interactions and (ii) their nuclei are
deficient in lamin A/C, a key component of the nuclear scaf-
fold that impacts the rigidity of the organelle (Lammermann
et al., 2008; Olins et al., 2009; Friedl et al., 2011; Rowat et al.,
2013; Wolf et al., 2013). The unusual ability of leukocytes to
rapidly infiltrate tissues is likely a required component of an
effective host defense system where microbes must be inter-
cepted quickly. While it is tempting to speculate that cancer
cells might adopt a similar phenotype, no neoplastic cell type
(save for those of myeloid origin) has yet been shown to dis-
play a similar capability. Indeed, though it has been opined
that leukocyte-centric schemes for traversing ECM barriers
may be relevant to cancer cell invasion schemes (Madsen &
Sahai, 2010), side-by-side comparisons—at least in vitro—
suggest otherwise (Sabeh et al., 2009;Wolf et al., 2013). That
is, whereas cancer cell invasion through type I collagen gels in
tightly linked to MT1-MMP-dependent collagenolytic activity
and the formationof collagen “tunnels”whose generation can
be inhibited completely by synthetic MMP inhibitors, human
polymorphonuclear leukocytes (PMNs), T-cells or monocytes
traverse the same collagen gels without degrading the col-
lagen matrix or leaving discernible tunnels (Fig. 1). Further,
whereas aggressive cancer cells require several days tomount
an invasion program through dense collagen barriers, human
leukocytes, particularly PMNs, complete the bulk of their in-
vasive activity within 4 h via a process that is unaffected by
MMP inhibitors or protease inhibitors cocktails (Fig. 1) (Huber
& Weiss, 1989; Sabeh et al., 2009). Similarly, though MT1-
MMP has been posited to play a direct role in macrophage
invasion (Sakamoto & Seiki, 2009), MT1-MMP-null mono-
cytes/macrophages display no major defects in transmigrat-
ing tissue barriers in vitro or in vivo following transfer of
MT1-MMP knockout bone marrow into wild-type recipients
(Xiong et al., 2009; Shimizu-Hirota et al., 2012). In amore re-
cent study, the conditional knockout of MT1-MMP in mouse
monocyte/macrophages resulted in subtle defects in cellular
infiltration whose mechanistic underpinnings remain to be
determined (Klose et al., 2013). Indeed, highlighting the com-
plexity of assigning specific functions to proteinases in intact
cell systems, MT1-MMP unexpectedly regulates macrophage
geneexpressionand immuneresponsesviaanovel proteinase-
independent mechanism requiring MT1-MMP intracellular
trafficking to the nuclear compartment (Shimizu-Hirota et al.,
2012).
Protease-independent migration in vitro: pepsin-extracted
collagen hydrogels and beyond
As animals age, the intramolecular crosslinks found in type I
collagen undergo a complex maturation process that renders
the molecules acid-insoluble (Sabeh et al., 2009). For com-
mercial purposes, large quantities of type I collagen can nev-
ertheless be recovered from animal dermis (primarily bovine
in origin) by employing a pepsin-extraction process that hy-
drolyzes the crosslink-rich telopeptide domains, leaving the
tripe-helical domains intact (Sabeh et al., 2009; Kreger et al.,
2010; Bailey et al., 2011). Like acid-extracted native collagen,
telopeptide domain-free collagenundergoes fibrillogenesis in a
pH-, ionic strength- and temperature-dependent fashion. The
polymerization process is, however, delayed relative to intact
type I collagen, and can yield hydrogels with larger diame-
ter fibrils and consequently, larger pore sizes (Kuznetsova &
Leikin, 1999; Olins et al., 2009). The degree to which fibril
diameter and pore size are altered remains the subject of some
debateas techniquesused to judge fibril dimensions, that is pri-
marily confocal reflection microscopy and second harmonic
generation, can underestimate fiber density or size while dis-
torting pore size estimates (Sato et al., 2000; Demou et al.,
2005; Jawerth et al., 2010; Kreger et al., 2010; Conklin et al.,
2011). Nevertheless, reports using pepsin-extracted bovine
dermal collagen (previously sold under the name, Vitrogen)
or pepsin-treated rat tail collagen, all concur that cancer cells
can rapidly infiltrate telopeptide-depleted collagen hydrogels
in a protease-independent fashion (Wolf et al., 2003; Sabeh
et al., 2004; Sodek et al., 2008; Packard et al., 2009; Sabeh
et al., 2009; Wolf et al., 2013). As new studies demonstrate
that the pore size of pepsin-extracted collagen hydrogels is
sufficiently large to accommodate the nuclear dimensions of
invading cancer cells (Wolf et al., 2013), these matrices may
well recapitulate the structural characteristics of loosely or-
ganized tissues in vivo (see further). In pepsinized collagen
hydrogels, however, the absence of intramolecular crosslinks
may also alter (i) matrix rigidity—and hence, cell behavior,
C© 2013 The Authors
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Fig.1. Collagen-invasiveanddegradativeactivitiesof cancercellsversus leukocytes.Lightmicrographsofcross-sectionsof type Icollagengels (2.2mg/mL)
traversed by HT-1080 or human PMNs prepared as described (Sabeh et al., 2009) for 3 d or 1 d, respectively. Collagen-invasive cells are H&E stained and
marked with black arrows. Double-headed arrowmarks the boundaries of the underlying collagen gel. Black bar= 100µm. Laser confocal micrographs
of HT-1080 cells cultured atop 3D gels of rhodamine-labeled type I collagen for 3 d demonstrate that invasion is associated with the formation of well-
demarcated tunnels (white arrows; white bar= 50µm). On the other hand, PMNs stimulated with zymosan-activated plasma (Huber andWeiss, 1989)
invade rhodamine-labeled collagen gels without perturbing matrix architecture (far right-hand panel). Invasion and collagen-degradative activities of
HT-1080, PMNs, T cells, and monocytes were quantified in the absence or presence of BB-2516 (1.5 µM) as described previously (bar graphs, bottom
panel) (Sabeh et al., 2004). PMN invasion was also assessed in the presence of the protease inhibitor cocktail prepared as described (Wolf et al., 2003).
Results are expressed as mean ± SEM (n = 4). Images and data are reproduced from the original work (Sabeh et al., 2009).
(ii) the ability of collagen fibers to bend and slide past one
anotherwith the application ofmechanical force, (iii) the abil-
ity of cells to transmit mechanical information across large
distances via tractional forces, and (iv) the sensitivity of the
telopeptide-free fibrils to collagenolytic attack (Woodley et al.,
1991; Discher et al., 2005; Perumal et al., 2008; Sander et al.,
2009;Winer et al., 2009;Ma et al., 2013). Even so, pepsinized
collagen gels can provide a useful model for interrogating the
means by which cells invade less-structured matrices though
the physiologic relevance ofmatrix constructs assembled from
telopeptide- and crosslink-depleted collagen remains unclear.
More ideally, perhaps, native collagengelsmaybe constructed
under conditionswhere pore size is purposefully varied (Sabeh
et al., 2009; Wolf et al., 2013). In fact, collagen fiber diameter
and pore size can be tuned by altering the temperature or pH
of gelation, though matrix rigidity is also altered under these
conditions (Mickel et al., 2008; Raub et al., 2008; Yang et al.,
2010). Indeed, native collagen gels can be traversed by neo-
plastic cells via protease-independent mechanisms if the pore
size is sufficiently large (Wolf et al., 2013). Nevertheless, due
appreciation of even ‘simple’ polymerization processes is re-
quired when formulating type I collagen hydrogels. “Minor”
changes in the preparation of collagen gels (e.g. the source
of acid-extracted type I collagen, the length of time that neu-
tralized collagen solutions are held at 4◦C prior to gelation or
the thickness of the cast gel) can all affect the physical prop-
erties of the hydrogels as well as the behaviour of embedded
cell populations (Jiang et al., 2000; Bailey et al., 2011; Carey
et al., 2012; Nguyen-Ngoc & Ewald, 2013). Likewise, as mi-
grating cellsmove closer to the edges of hydrogels constructed
within rigid supports (i.e. glass or plastic containers), abrupt
increases in matrix rigidity occur at the gel-support interface
via edge effects that can also impact cell phenotype (Rao et al.,
2012).
Independent of these cautionary notes, hydrogel pore size
is an important determinant of protease-dependent versus
C© 2013 The Authors
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proteinase-independentmigrationschemes(Wolf etal.,2013).
Interestingly, even in the absence of ECM barriers that require
proteolytic remodelling, marked changes are observed in the
motile strategies used by cancer cells to traverse variably sized
channel diameters in micro-engineered migration chambers
(Rolli et al., 2010; Balzer et al., 2012; Pathak & Kumar, 2012;
Tong et al., 2012). Most remarkably, confining carcinoma
cells to increasingly smaller channel diameters, Balzer andcol-
leagues demonstrated thatmotility switches froman integrin-
and actomyosin-dependent mechanism to one that relies on
microtubule dynamics alone (Balzer et al., 2012).
Devil in the details: Amoeboid-type invasion patterns in vivo
Until recently, many groups concluded that cancer cells read-
ily traverse type I collagen barriers by adopting an amoeboid
phenotype characterizedby its insensitivity tobroad-spectrum
proteinase inhibitors (for review, see Sabeh et al., 2009). We
now know, however, that a wide variety of cancer cell types
are absolutely dependent on MT1-MMP when confronting
crosslinked type I collagen barrierswhosemeanpore diameter
requires changes in nuclear shape that exceed the maximal
deformability of the nuclear envelope (Sabeh et al., 2009;Wolf
et al., 2013). Nevertheless, cancer cells can potentially adopt
a protease-independent stance when negotiating structural
barriers that can either accommodate the semi-deformable
nuclear envelope or prove sensitive to mechanical displace-
ment. Presently, however, little is known with regard to the
size or structural characteristics of ECM pore sites encoun-
tered within the interstitial compartment in vivo (Sabeh et al.,
2009; Wolf et al., 2009). Keeping in mind the limitations as-
sociatedwith documenting pore size by confocal reflectionmi-
croscopy or second harmonic generation alone (Conklin et al.,
2011), in vivo tissue estimates have ranged from 4 to 10 µm2
“micropores” to 40 to 1000 µm2 ‘macropores’ (Wolf et al.,
2009). These results raise the possibility that collagen con-
structs assembled in vitromay not recapitulate fully the more
complex networks assembled in vivo. However, it should be
noted that defects in vascular smooth muscle cell migration,
adipocyte differentiation and stem cell lineage commitment
observed in MT1-MMP-targeted mice have been duplicated
in vitro using dense, acid-extracted type I collagen hydrogels
(Filippov et al., 2005; Chun et al., 2006; Tang et al., 2013).
Even so, given the more simple composition of type I colla-
gen hydrogels relative to the interstitial matrix in vivo, cancer
cell migration into tissue explants has also been used as an
alternative, albeit, empirical means for assessing the obligate
versus disposable roles of proteases during trafficking through
‘authentic’ matrix pores (Sabeh et al., 2004; Nurmenniemi
et al., 2009; Sabeh et al., 2009; Booth et al., 2012). When
cultured atop acellular human dermal explants, cancer cell
invasion has been reported to proceed only in the presence of
MT1-MMP-dependent activity (Sabeh et al., 2004). Whereas
the preparation of acellular explants potentially distorts the
pore architecture of native tissues, live explants have also been
used as a platform for assessing the protease-dependent versus
protease-independent invasive activity of cancer cells (Sabeh
et al., 2009). Under these more in vivo-like conditions, cancer
cell organoids were inoculated into intact human mammary
gland tissues. Thoughmonitoring of invasive activitywas lim-
ited to a short-term, 3-day culture period, cancer cells failed
to infiltrate the surrounding tissues in the absence of MT1-
MMP activity (Sabeh et al., 2009). Likewise, MT1-MMP has
been shown to support metastatic behaviour of breast cancer
cells in mouse models in vivo (Perentes et al., 2011). As little
evidence of protease-independent invasive activity has been
observed in these scenarios, these results support—at least
under these specific conditions—the presence of an intersti-
tial matrix pore size that cancer cells are unable to negotiate
without mobilizing proteolytic activity.
Of course, ex vivo efforts to directly track patterns of cell
invasion fall short of recapitulating the daunting complexi-
ties of the in vivo environment. Nevertheless, several groups
have launched efforts to characterize cancer cell motility in
vivo and the results have, to varying degrees, been illuminat-
ing (Provenzano et al., 2009; Friedl et al., 2012; Weigelin,
2012). Estimates of matrix pore size in normal tissues pro-
vide insight into the potential trafficking constraints encoun-
tered by invading cells under baseline conditions (Wolf et al.,
2009). However, primary tumour sites are frequently associ-
ated with the deposition of dense bands of interstitial collagen
that increasematrix density and rigidity (Levental et al., 2009;
Provenzano et al., 2009). Indeed, in syngeneic mouse models
of breast cancer, neoplastic cells interface directly with colla-
gen fibrils that appear to present invading cells with a phys-
ical barrier to passive movement (Provenzano et al., 2009).
Further, in mouse models of breast cancer, neoplastic cells
at the invading front have been observed to contain large
quantities of ingested type I collagen, a finding consistent
with the proposition that active collagenolysis is integral to
the invasion process as cells confront tissue barriers in vivo
(Curino et al., 2005). Interestingly, the diameter of collagen
fibers deposited at neoplastic sites in vivo also matches that
of self-polymerizing collagen hydrogels prepared from acid-
extracted type I collagen under standard conditions (Oldberg
et al., 2007). Nevertheless, despite indications that neoplas-
tic cells encounter collagenous barriers in vivo that necessi-
tate proteolytic remodelling, other studies have documented
the appearance of rapidly migrating cancer cell populations
that move with a rapid, amoeboid-like morphology (Madsen
& Sahai, 2010). Furthermore, the invasive potential of these
cells appears to be insensitive to MMP inhibitors in the in vivo
setting (Wolf et al., 2003; Madsen & Sahai, 2010). Whereas
the observed migration patterns are certainly consistent with
cancer cell movement through larger, non-constraining ma-
trix pores, these results alternatively reflect the ability of can-
cer cells to rapidly migrate through proteolytically precleared
tunnels via proteinase-independent processes similar to those
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observed in vitro (Sabeh et al., 2004; Gaggioli et al., 2007;
Fisher et al., 2009; Carey et al., 2013). Interestingly, more
recentworksupports,however, a lower speedof invasion in tu-
mour in the in vivo setting, perhaps reflecting requirements for
a proteinase-dependent invasion schemes (Weigelin, 2012).
Distinguishing between these two possibilities remains diffi-
cult andwill require determined efforts to track themovement
of syngeneic tumours from their primary site of origin.
What more is to be done? A proposition and way forward
In vitro studies allow for the formulation of specific ques-
tions and the design of rigorous experimental approaches.
However, the testing of even “simple” models will require
the melding of expertise in ECM biochemistry, bioengineer-
ing, cell biology, enzymology and sophisticated imaging tech-
nologies, a mix of skill sets seldom if ever found within
a single laboratory group (Morell et al., 2013). Further-
more, by venturing into the in vivo setting, additional ex-
pertise will be needed in cancer biology and animal mod-
elling as well as the application of specific interventions for
silencing proteolytic systems. Attempts to target MMPs in
vivo—and this assumes that MMPs play a preeminent role
in invasion as opposed to other proteolytic systems—have
been confined largely to nonspecific small molecule inhibitors
whose efficacy remains the subject of debate (though hu-
manized anticatalytic monoclonal antibodies directed against
MT1-MMP have been characterized recently) (Devy et al.,
2009). Whereas tissue-specific knockouts are seldom em-
ployed for these studies, cooperative interactionsbetweencan-
cer cells and stromal cell populations further complicate efforts
to identify a single, monolithic player (Gaggioli et al., 2007;
Kessenbrock et al., 2010). Indeed, unpublished efforts ongoing
in the Weiss laboratory are focusing on the use of MT1-MMP
and MT2-MMP floxed mice to clarify the role of the epithelial-
and stromal-derived proteinases in regulating the invasion
programs associated with normal mammary gland branch-
ingmorphogenesis andmammary gland tumorigenesis. Even
with all the necessary tools in hand, we cannot overstress
the complexities of an ECM comprised of self-polymerizing
molecules that can be crosslinked into novel structures by
only recently defined processes (Rowe & Weiss, 2008; Vana-
core et al., 2009; Bhave et al., 2012; Ilani et al., 2013). More-
over, in terms of understanding mechanisms underlying can-
cer cell intravasation and extravasation, epithelial BMs likely
display characteristics distinct from vascular and lymphatic
BMs (Rowe&Weiss,2008;Pflicke&Sixt,2009;Rowe&Weiss,
2009), and it is not clear that invasion through the abluminal
side of a BM into a vascular/lymphatic network (i.e. intravasa-
tion) is equivalent to transmigration from the luminal face of a
BM into surrounding stromal tissues (i.e. extravasation). Pop-
ular, but perhaps, overly simplistic, cartoon-like depictions of
the complex cancer cell-stromal-ECM interface are unlikely to
shed new insights into these dynamic environments.Without
expending effort to separate dogma from fact, progress in the
field will likely be stifled or misguided. New insights into the
regulation of the dynamic cancer cell-ECM interface will no
doubt require ‘team efforts’ that couple state-of-the-art tech-
nologies with scientific rigor. Dividends from these enterprises
will accelerate the development of the necessary tools to per-
mit the simultaneous analysis of changes in ECM structure
and function as tumour cells infiltrate the 3-D ECM in vitro
and in vivo. The identification and specific targeting of the key
proteolytic—ornonproteolytic—systemsthatdrivecancercell
invasion in validated model systems should then allow for the
resolution of outstanding questions in the field and pave the
way for the intelligent design of new interventions.
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